Dylan Meyer

Dylan Meyer, Ph.D., currently serves as a Research Scientist at Vertex Pharmaceuticals since July 2022, focusing on electrophysiology and pharmacology alongside human cell model development and CRISPR-Cas9 techniques. Prior to this role, Dylan was a Postdoctoral Research Fellow at Harvard Medical School from September 2019 to July 2022, specializing in neurophysiology, cell biology, and mitochondrial metabolism while employing advanced imaging and data analysis techniques. Academic credentials include a Ph.D. in Biomedical Sciences with a concentration in Translational Neuroscience and Pharmacology from Texas Tech University Health Sciences Center and a Bachelor of Science in Applied Science with a focus on Biotechnology from the University of Wisconsin-Stout. Additionally, extensive research experience encompasses various roles in cell physiology and molecular biophysics across multiple institutions, involving electrophysiological methods, site-directed mutagenesis, and proteomics.